Researcher
Hans Prenen
- Keywords (University of Antwerp):Medicine
- Disciplines (University of Antwerp):Cancer biology, Cancer diagnosis, Cancer epidemiology, Cancer prevention, Cancer therapy
- Disciplines (KU Leuven):Morphological sciences, Oncology
- See also: Hans Prenen (KU Leuven)
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Oct 2020 → Today - Laboratory of Tumor Inflammation and Angiogenesis (VIB-KU Leuven) (Division)
Member
From12 Jul 2017 → 30 Apr 2018 - Clinical Digestive Oncology (Division)
Member
From1 Jan 2012 → 23 Jul 2017 - Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2009 → 31 Dec 2011
Projects
1 - 2 of 2
- Development of an image-based multiparametric drug response signature to predict clinical therapy response in cancer patients from ex vivo tumoroid screenings.From1 Oct 2022 → TodayFunding: BOF - doctoral mandates
- Reinvigorating the antitumor immunity in human breastand cervical cancer with an innovative RANK(L) targeted combination strategy.From1 Nov 2021 → TodayFunding: Nonprofit institution or equivalents
Publications
1 - 10 of 139
- GWAS meta-analysis of 16 790 patients with Barrett’s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level(2023)
Authors: Julia Schröder, Laura Chegwidden, Carlo Maj, Jan Gehlen, Jan Speller, Anne C. Böhmer, Oleg Borisov, Timo Hess, Nicole Kreuser, Marino Venerito, et al.
Pages: 612 - 623 - Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding(2023)
Authors: Carla Riera-Domingo, Eduarda Leite-Gomes, Iris Charatsidou, Peihua Zhao, Giovanna Carra, Federica Cappellesso, Larissa Mourao, Maxim De Schepper, Dana Liu, Jens Serneels, et al.
Pages: 1 - 25 - New developments in treating RAS-mutated metastatic colorectal cancer(2023)
Authors: Katleen Janssens, Chinouk Lambrechts, Barbara Geerinckx, Ken Op de Beeck, Guy Van Camp, Helena Oliveres, Hans Prenen, Timon Vandamme, Marc Peeters
Pages: 965 - 987 - A Belgian population-based study reveals subgroups of right-sided colorectal cancer with a better prognosis compared to left-sided cancer(2023)
Authors: Katleen Janssens, Erik Fransen, Guy Van Camp, Hans Prenen, Ken Op de Beeck, Nancy Van Damme, Marc Peeters
Pages: e331 - e340 - A phase I trial of the dual MET Kinase/OCT-2 inhibitor OMO-1 in metastatic solid malignancies including MET exon 14 mutated lung cancer(2023)
Authors: Melinda A. Pruis, Matthew G. Krebs, Ruth Plummer, Filip De Vos, Eric Angevin, Hans Prenen, Martin D. Forster, Glen Clack, Annegret van der Aa, Marc Tjwa, et al.
Pages: 1 - 11 - The role of immunotherapy in esophageal and gastric cancer(2023)
Authors: Hans Dedecker, Laure-Anne Teuwen, Timon Vandamme, Hans Prenen
Pages: 175 - 182 - Comprehensive genomic profiling and therapeutic implications for patients with advanced cancers(2023)
Authors: Laure-Anne Teuwen, Evelyne Roets, Pieter D'Hoore, Patrick Pauwels, Hans Prenen
Pages: 1 - 14 - Extensive CArdioVAscular characterization and follow-up of patients receiving immune checkpoint inhibitors(2023)
Authors: Johan De Sutter, Lieselot Croes, Delphine Vervloet, Veronique Moerman, Nico Van de Veire, Anne-Marie Willems, Marc Peeters, Hans Prenen, Christof Vulsteke
Pages: 1 - 14 - Immediate hypersensitivity reactions to antineoplastic agents(2023)
Authors: Sofie Seghers, Laure-Anne Teuwen, Michiel Beyens, Dennis De Blick, Didier Ebo, Hans Prenen
Pages: 1 - 13 - Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in patients with cancer(2023)
Authors: Yana Debie, Jonas Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Greetje Vanhoutte, Elly Marcq, Lisa Verheggen, Maria Goossens, Pieter Pannus, et al.
Pages: 635 - 646